How to Become a AI Regulatory Affairs Specialist

Create a complete simulated 510(k) submission package for a fictional AI-powered medical imaging analysis tool. Includes device description, substantial equivalence comparison with a predicate device, performance validation report, software documentation per IEC 62304, risk management file per ISO 14971, and labeling. Use a real open-source medical imaging model as the product under review.

Build a Python-based pipeline that ingests model predictions and demographic data, runs Fairlearn and custom fairness metrics across protected attributes (age, sex, race, insurance status), generates a comprehensive fairness report in PDF format, and flags statistically significant performance gaps. Use the MIMIC-III or eICU clinical dataset as a test case.

Design and document a reusable PCCP template aligned with FDA guidance, including sections for the Software Change Protocol, Modified ML Algorithm Description, Pre-Specified Performance Validation Plan, and Re-Training Data Management Plan. Populate it for a hypothetical adaptive sepsis prediction model with example content.

Build a Grafana or Tableau dashboard that tracks real-time model performance metrics (sensitivity, specificity, AUC, calibration) alongside demographic disaggregation, data drift indicators, and adverse event counts for a deployed clinical AI tool. Integrate with simulated incoming data streams using AWS SageMaker Model Monitor or a local equivalent.

Create an interactive checklist tool (in Notion, Airtable, or a simple web app) that maps the EU AI Act's high-risk AI system requirements (Annex IV, Articles 9-15) against an AI health product's current documentation state. Each requirement is linked to evidence items, compliance status, and gap-filling action items.

Take an existing open-source healthcare AI model from HuggingFace or GitHub (e.g., a chest X-ray classifier or clinical NER model) and author a comprehensive model card that goes beyond the standard template to include regulatory-relevant sections: clinical intended use, validation methodology, demographic performance, known limitations, regulatory pathway considerations, and post-market monitoring recommendations.

Research and produce a comparative regulatory strategy document for bringing an AI-powered clinical decision-support tool to market in the US (FDA), EU (MDR + AI Act), UK (MHRA), and a third market (e.g., Japan PMDA or Australia TGA). Include classification analysis, submission timelines, required documentation differences, and harmonized approach recommendations.